Literature DB >> 12952973

The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore.

Andrea M Cesura1, Emmanuel Pinard, Robert Schubenel, Valerie Goetschy, Arno Friedlein, Hanno Langen, Peter Polcic, Michael A Forte, Paolo Bernardi, John A Kemp.   

Abstract

The relevance of the mitochondrial permeability transition pore (PTP) in Ca2+ homeostasis and cell death has gained wide attention. Yet, despite detailed functional characterization, the structure of this channel remains elusive. Here we report on a new class of inhibitors of the PTP and on the identification of their molecular target. The most potent among the compounds prepared, Ro 68-3400, inhibited PTP with a potency comparable to that of cyclosporin A. Since Ro 68-3400 has a reactive moiety capable of covalent modification of proteins, [3H]Ro 68-3400 was used as an affinity label for the identification of its protein target. In intact mitochondria isolated from rodent brain and liver and in SH-SY5Y human neuroblastoma cells, [3H]Ro 68-3400 predominantly labeled a protein of approximately 32 kDa. This protein was identified as the isoform 1 of the voltage-dependent anion channel (VDAC). Both functional and affinity labeling experiments indicated that VDAC might correspond to the site for the PTP inhibitor ubiquinone0, whereas other known PTP modulators acted at distinct sites. While Ro 68-3400 represents a new useful tool for the study of the structure and function of VDAC and the PTP, the results obtained provide direct evidence that VDAC1 is a component of this mitochondrial pore.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952973     DOI: 10.1074/jbc.M304748200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria.

Authors:  Ran Zalk; Adrian Israelson; Erez S Garty; Heftsi Azoulay-Zohar; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

2.  Bacterial expression, purification and characterization of a rice voltage-dependent, anion-selective channel isoform, OsVDAC4.

Authors:  Ashwini Godbole; Rohan Mitra; Ashvini K Dubey; Palakolanu S Reddy; M K Mathew
Journal:  J Membr Biol       Date:  2011-11-06       Impact factor: 1.843

Review 3.  The role of VDAC in cell death: friend or foe?

Authors:  Kyle S McCommis; Christopher P Baines
Journal:  Biochim Biophys Acta       Date:  2011-10-28

4.  On the role of VDAC in apoptosis: fact and fiction.

Authors:  Tatiana K Rostovtseva; Wenzhi Tan; Marco Colombini
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

5.  A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC.

Authors:  Johnathan C Lai; Wenzhi Tan; Luba Benimetskaya; Paul Miller; Marco Colombini; C A Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

6.  "Nanosized voltmeter" enables cellular-wide electric field mapping.

Authors:  Katherine M Tyner; Raoul Kopelman; Martin A Philbert
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

Review 7.  The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines; Manuel Gutiérrez-Aguilar
Journal:  Cell Calcium       Date:  2018-05-16       Impact factor: 6.817

Review 8.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

9.  The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.

Authors:  Anna W C Leung; Pinadda Varanyuwatana; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

Review 10.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.